Physician profile
Anthony G Johnson
NPI 1104995240
$13,238.71
in general payments reported to CMS, 2019-2025
27 companies · $4,705 in 2025
The $4,705 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,523 · 2020: $565 · 2021: $299 · 2022: $270 · 2023: $222 · 2024: $656 · 2025: $4,705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,119 · Food and Beverage: $2,464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,118.84 |
| Food and Beverage | $2,463.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $4,525.67 | 2019-2020 | |
| Medtronic, INC. | $3,788.65 | 2021-2025 | Linq II, Micra, Symplicity G3 |
| Biotronik INC. | $1,592.39 | 2019 | |
| Boston Scientific Corporation | $1,029.84 | 2021-2025 | Ingevity+, Blazer II |
| Janssen Pharmaceuticals, INC | $436.69 | 2019-2024 | Xarelto |
| Ge Healthcare | $363.00 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $189.54 | 2019-2025 | Eliquis, Camzyos |
| Sanofi-Aventis U.S. LLC | $189.43 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $124.88 | 2019-2024 | |
| Astrazeneca Pharmaceuticals Lp | $113.90 | 2019-2021 | |
| Portola Pharmaceuticals, LLC | $101.74 | 2019-2020 | |
| Amgen INC. | $100.94 | 2020-2024 | Repatha |
| Pfizer INC. | $98.85 | 2019-2024 | |
| Abbott Laboratories | $84.40 | 2019-2023 | Mitraclip |
| Chiesi USA, INC. | $83.30 | 2020-2025 | Kengreal, Cleviprex |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $78.45 | 2019-2025 | Uptravi, Opsynvi |
| Elutia, INC. | $60.07 | 2020 | |
| Impulse Dynamics (USA) INC. | $54.42 | 2023-2024 | Optimizer, Optimizer |
| Baxter Healthcare | $35.63 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Kestra Medical Technology Services, INC. | $34.11 | 2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.35 | 2020-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.10 | 2019 | |
| Philips North America LLC | $22.48 | 2023 | |
| Amarin Pharma, INC. | $20.14 | 2020 | |
| Csl Behring | $18.79 | 2019 | |
| Bridgebio Pharma, INC. | $17.51 | 2025 | Attruby |
| Cardinal Health 200 LLC | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.